NCT03914950 TOF-18F-FDG-PET/CT in Patients With Suspected Pancreatic Cancer Status COMPLETED Phase NA
NCT03908333 High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer Status WITHDRAWN Phase PHASE1/PHASE2
NCT03906331 Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation Status APPROVED_FOR_MARKETING Phase N/A
NCT03902600 A Study of Photon and Proton Chemoradiotherapy as Definitive or Neoadjuvant Therapy in Non-Metastatic Pancreatic Cancer Status COMPLETED Phase N/A
NCT03891979 Gut Microbiome Modulation to Enable Efficacy of Checkpoint-based Immunotherapy in Pancreatic Adenocarcinoma Status WITHDRAWN Phase PHASE4
NCT03886571 U01-Biomarkers for Noninvasive and Early Detection of Pancreatic Cancer Status UNKNOWN Phase N/A
NCT03883919 Liposomal Irinotecan Plus 5-FU / LV Combined With Paricalcitol in Patients With Advanced Pancreatic Cancer Progressed on Gemcitabine-based Therapy Status COMPLETED Phase PHASE1
NCT03882866 Iodine-125 Seed Implantation Therapy for Locally Advanced Pancreatic Cancer Status UNKNOWN Phase NA
NCT03871790 Peptide-based Immunization for Colon- and and Pancreas-carcinoma Status COMPLETED Phase N/A
NCT03869294 GS Regimen as the First-line Chemotherapy in Chinese Advanced PC Patients Status COMPLETED Phase N/A
NCT03851133 Florida Pancreas Collaborative Next Generation Biobank Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03848182 Analyzing Childhood Recall Antigens in Patients With Pancreatic Cancer Status TERMINATED Phase PHASE2
NCT03829748 Intermittent Suction Technique in the Diagnosis of Pancreatic Solid Lesions Status COMPLETED Phase NA
NCT03829501 A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies Status TERMINATED Phase PHASE1/PHASE2
NCT03829436 TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers Status COMPLETED Phase PHASE1
NCT03825328 A Trial of NS/GEMOX Chemotherapy in Patients With Untreated Pancreatic Cancer ( HZ-NS/GEMOX-PC ) Status UNKNOWN Phase PHASE2
NCT03821909 Acquisition of Portal Venous CTCs and Exosomes From Patients With Pancreatic Cancer by EUS Status UNKNOWN Phase N/A
NCT03820921 Evaluation of MMR Status and PD-L1 Expression Using Specimens Obtained by EUS-FNB in Patients With Pancreatic Cancer Status UNKNOWN Phase N/A
NCT03820544 SEMS Placement Before Surgery in Unblocking Bile Duct in Patients With Periampullary Pancreatic Cancer With Severe Obstructive Jaundice Status TERMINATED Phase NA